Earlier, Pain Therapeutics and King have entered into a strategic alliance to develop and commercialize Remoxy and other abuse-resistant opioid painkillers, in 2005.
Remoxy, developed by Pain Therapeutics, using Durect’s Oradur technology, is a formulation of oral oxycodone, which is a twice daily medicine for severe pain requiring continuous, around-the-clock opioid treatment for an extended period of time.
Durect claims that its Oradur sustained released oral gel-cap technology provides the unique characteristics of Remoxy and the referenced follow-on products.